Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus

    • AGGX Gross Margin

    As of 2025-07-15, the Gross Margin of Angiogenex Inc (AGGX) is N/A.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    AGGX Gross Margin - Peers Comparison
    TickerNameValue
    ACURAcura Pharmaceuticals Inc100%
    AHROQAtheroNova Inc-
    AOLSAeolus Pharmaceuticals Inc7775.2%
    APPBApplied Biosciences Corp26.2%
    BTHEBoston Therapeutics Inc-24304.1%
    BVXVBiondVax Pharmaceuticals Ltd7775.2%
    CBGLCannabis Global, Inc.11.3%
    CDXICardax Inc63.6%
    CNTXContext Therapeutics Inc7775.2%
    CTTHCTT Pharmaceutical Holdings Inc7775.2%
    GBLXGB Sciences Inc6.1%
    GFGVFFast Line Holding Inc-
    GLPHGala Pharmaceutical Inc31.2%
    IASOIASO Pharma Inc-
    LCARLescarden Inc89.1%
    LILY.CNCallitas Health Inc72.6%
    MDCNMedican Enterprises Inc7775.2%
    NBGVNewBridge Global Ventures Inc29.6%
    NPTXNeuropathix Inc100%
    PHBIPharmagreen Biotech Inc51%
    PSIQProfile Solutions Inc7775.2%
    PTEOProteo Inc7775.2%
    QNTAQuanta Inc78.7%
    SNNAQSienna Biopharmaceuticals Inc7775.2%
    STLTSpotlight Innovation Inc-5582.5%
    SYNISynvista Therapeutics Inc-
    TCDATricida Inc-